MEET QPS AT AD/PD™ 2024; March 5-9, Lisbon, Portugal

Blog

Could Pesticides Lead to Parkinson’s Disease?
QPS Neuro
Tractor spraying pesticide over crops
Neurological disorders are now the leading source of disability around the world. Within that category, Parkinson’s Disease (PD) is the fastest-growing neurological disorder, impacting more than 8.5 million people globally. Researchers have identified a number of environmental factors that contribute to the disease’s unprecedented rise — and the evidence is increasingly pointing to pesticides. Unfortunately, …
Read More
Is mRNA the Key to Treating Parkinson’s Disease?
QPS Neuro
Digital illustration of the cell nucleus in the interphase - DNA, mRNA, nucleolus and several enzymes
Parkinson’s Disease (PD) impacts as many as 500,000 Americans, though some estimates put that number as high as 1 million. There is currently no cure for PD, which means that healthcare providers are constantly on the lookout for effective therapeutic treatments to improve patients’ quality of life. Now, researchers at the Scripps Research Institute have developed a new …
Read More
Could Malfunctioning Mitochondria Predict Alzheimer’s Disease?
QPS Neuro
mitochondria
Alzheimer’s Disease, or AD, is an incurable neurodegenerative condition that generally appears in individuals over the age of 65. However, scientists now believe that certain predictors can appear in a patient’s brain decades before symptoms appear — specifically, malfunctioning mitochondria. With that in mind, researchers at the European Synchrotron Radiation Facility (ESRF) recently posed an …
Read More
New Study Advances Multiple Sclerosis Vaccine Prospects
QPS Neuro
Close-up of vaccine
More than 1.8 million people worldwide are diagnosed with multiple sclerosis (MS), a chronic autoimmune disease that impacts everyday function, including balance, cognition, and physical strength. Previous research has indicated a link between MS and the Epstein–Barr virus (EBV), a highly contagious double-stranded DNA virus thought to cause an autoimmune reaction in some patients. Now, …
Read More
New Technology Expands Gene Therapy Delivery Options
QPS Neuro
graphic illlustration of adeno-associated virus
Gene therapy clinical trials using adeno-associated virus (AAV) vectors for gene transfer are on the rise. AAV vectors are an appealing choice for gene therapy applications because of their strong safety profile, long-term gene expression, and high-efficiency transduction into a wide range of target tissues. Despite these advantages, there are limitations: AAV vectors have limited …
Read More
12315 Next

Trending

Newsletter